Skip to main content
SpringerLink
Log in

Leptin levels in Henoch–Schönlein purpura

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this paper is to assess the possible role of nitric oxide (NO) and leptin in Henoch–Schönlein purpura (HSP). We investigated the serum leptin and total nitrite levels in 22 children with HSP in the acute phase and after remission and in 20 age- and sex-matched healthy control. Serum leptin levels (nanograms per milliliter; median, min–max) were statistically higher in the acute phase (12.9, 9.1–19.5) than those in the remission phase (6.1, 3.7–10.5, p<0.001) and in the control group (4.9, 3.8–7.5, p<0.001). Also, serum nitrite levels (micromole per liter; median, min–max) were higher in children in the acute phase (45.0, 32.0–60.0) compared to those in remission phase (30.5, 23.0–48.0) and in the control group (29.5, 18.0–38.0) (p<0.001, p<0.001, respectively). There was a positive correlation between serum leptin and total nitrite levels (r=0.65, p<0.001). We have demonstrated that serum leptin and NO levels were increased during the acute phase in children with HSP, and returned to normal levels in remission. We suggest that leptin and NO may have a role in the immunoinflammatory process of HSP, especially in the acute phase. Further studies are needed to clearly establish the roles of leptin and NO in the pathogenesis of HSP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tizard EJ (1999) Henoch–Schönlein purpura. Arch Dis Child 80:380–383

    Article  PubMed  CAS  Google Scholar 

  2. Muslu A, Islek I, Gok F, Aliyazicioglu Y, Dagdemir A, Dundaroz R et al (2002) Endothelin levels in Henoch–Schönlein purpura. Pediatr Nephrol 17:920–925

    Article  PubMed  Google Scholar 

  3. Besbas N, Saatci U, Ruacan S, Ozen S, Bakkaloglu A, EL Nahas AM (1997) The role of cytokines in Henoch–Schonlein purpura. Scand J Rheumatol 26:456–460

    PubMed  CAS  Google Scholar 

  4. Gattorno M, Vignola S, Barbano G, Sormani MP, Sabatini F, Buoncompagni A et al (2000) Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch–Schonlein purpura and pediatric systemic lupus erythematosus. J Rheumatol 27:2251–2255

    PubMed  CAS  Google Scholar 

  5. Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY (1996) Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schonlein–Henoch purpura. Nephron 74:79–88

    PubMed  CAS  Google Scholar 

  6. Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y (1998) Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch–Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol 114:468–476

    Article  PubMed  CAS  Google Scholar 

  7. Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE et al (1997) Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab 82:3408–3413

    Article  PubMed  CAS  Google Scholar 

  8. Hibbs JBJ, Taintor RR, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87–94

    Article  PubMed  CAS  Google Scholar 

  9. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142

    PubMed  CAS  Google Scholar 

  10. de Belder AJ, Radomski MW, Martin JF, Moncada S (1995) Nitric oxide and the pathogenesis of heart muscle disease. Eur J Clin Invest 25:1–8

    PubMed  Google Scholar 

  11. Islek I, Balat A, Cekmen M, Yureklı M, Muslu A, Sahinoz S et al (2003) Adrenomedullin and total nitrite levels in children with Henoch–Schönlein purpura. Pediatr Nephrol 18:1132–1137

    Article  PubMed  Google Scholar 

  12. Soylemezoglu O, Ozkaya O, Erbas D, Akkok N, Buyan N, and Hasanoglu E (2002) Nitric oxide in Henoch–Schönlein purpura. Scand J Rheumatol 31:271–274

    Article  PubMed  Google Scholar 

  13. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Behcet’s disease: is it a new activity marker? J Am Acad Dermatol 46:50–54

    Article  PubMed  Google Scholar 

  14. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch–Schonlein purpura. Arthritis Rheum 33:1114–1121

    PubMed  CAS  Google Scholar 

  15. Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr (1996) Measurement of nitrate and nitrite in biological samples using nitrate reductase and Greiss reaction. Methods Enzymol 268:142–151

    PubMed  CAS  Google Scholar 

  16. Moshage H (1997) Nitric oxide determinations: much ado about NO-thing? Clin Chem 43:553–556

    PubMed  CAS  Google Scholar 

  17. Evereklioglu C, Inaloz HS, Kirtak N, Doganay S, Bulbul M, Ozerol E et al (2002) Serum leptin concentration is increased in patients with Behcet’s syndrome and is correlated with disease activity. Br J Dermatol 147:331–336

    Article  PubMed  CAS  Google Scholar 

  18. Stenvinkel P, Lönnqvist F, Schalling M (1999) Molecular studies of leptin: implications for renal disease. Nephrol Dial Transplant 14:1103–1112

    Article  PubMed  CAS  Google Scholar 

  19. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Tumour necrosis factor- contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2772–2782

    Article  Google Scholar 

  20. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP (1997) Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 82:3408–3413

    Article  Google Scholar 

  21. Wu T, Wu S, Huang T, Yu C, Tsai C (1996) Increased excretion of Tumor necrosis factor alpha and interleukin-1 in urine from patients with IgA nephropathy and Schönlein–Henoch Purpura. Nephron 74:79–88

    Article  PubMed  CAS  Google Scholar 

  22. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142

    PubMed  CAS  Google Scholar 

  23. Bratt J, Palmbland J (1997) Cytokine-Induced neutrophil-mediated injury of human endothelial cells. J Immunol 159:912–918

    PubMed  CAS  Google Scholar 

  24. Tsukahara H, Kikuchi K, Matsuda M et al (1997) Endogenous nitric oxide production in Kawasaki disease. Scand J Clin Lab Invest 57:43–47

    Article  PubMed  CAS  Google Scholar 

  25. Er H, Evereklioglu C, Cumurcu T, Turkoz Y, Ozerol E, Sahin K et al (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet’s disease. Br J Ophthalmol 86:653–659

    Article  PubMed  CAS  Google Scholar 

  26. Heeringa P, Bijl M, de Jager-Krikken A, Zandvoort A, Dijkstra G, Moshage H et al (2001) Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener’s granulomatosis. J Pathol 193:224–232

    Article  PubMed  CAS  Google Scholar 

  27. Trachtman H, Gauthier B, Frank R, Futterweit S, Goldstein A, Tomozak J (1996) Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J Pediatr 128:173–176

    Article  PubMed  CAS  Google Scholar 

  28. Cattell V (2002) Nitric oxide and glomerulonephritis. Kidney Int 61:816–821

    Article  PubMed  CAS  Google Scholar 

  29. Svenungsson E, Andersson M, Brundin L (2001) Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 60:372–379

    Article  PubMed  CAS  Google Scholar 

  30. Beltowski J, Jochem J, Wojcicka G, Zwirska-Korczala K (2004) Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat. Regul Pept 120:59–67

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Medicine, Ondokuz Mayis University, 55139, Samsun, Turkey

    Yuksel Aliyazicioglu & Muhlise Alvur

  2. Department of Pediatric Nephrology, Faculty of Medicine, Ondokuz Mayis University, 55139, Samsun, Turkey

    Ozan Ozkaya

  3. Department of Pediatrics, Faculty of Medicine, Ondokuz Mayis University, 55139, Samsun, Turkey

    Husamettin Yakut & Ismail Islek

Authors
  1. Yuksel Aliyazicioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozan Ozkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Husamettin Yakut
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ismail Islek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Muhlise Alvur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuksel Aliyazicioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aliyazicioglu, Y., Ozkaya, O., Yakut, H. et al. Leptin levels in Henoch–Schönlein purpura. Clin Rheumatol 26, 371–375 (2007). https://doi.org/10.1007/s10067-006-0363-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0363-6

Keywords

Search

Navigation